[go: up one dir, main page]

CA1271966C - Aryl and aralkyl sulfonyl l-prolines - Google Patents

Aryl and aralkyl sulfonyl l-prolines

Info

Publication number
CA1271966C
CA1271966C CA615516A CA615516A CA1271966C CA 1271966 C CA1271966 C CA 1271966C CA 615516 A CA615516 A CA 615516A CA 615516 A CA615516 A CA 615516A CA 1271966 C CA1271966 C CA 1271966C
Authority
CA
Canada
Prior art keywords
prolines
aryl
formula
aralkyl sulfonyl
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA615516A
Other languages
French (fr)
Other versions
CA1271966A (en
Inventor
John Krapcho
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000615516A priority Critical patent/CA1271966A/en
Application granted granted Critical
Publication of CA1271966C publication Critical patent/CA1271966C/en
Publication of CA1271966A publication Critical patent/CA1271966A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

ABSTRACT This invention provides new aryl and aralkyl sulfonyl L-prolines of the formula wherein: R is hydrogen or lower alkyl; m is zero or an integer from 1 to 4; R1 , a 1- or 2-naphthyl of the formula , or which are useful as intermediates in the preparation of new acyl mercaptoalkanoyl and mercaptoalkanoyl derivatives of aryl and aralkyl sulfonyl prolines of the formula IMG> which possess angiotensin converting enzyme inhibition activity and thus are useful as anti-hypertensive agents.
CA000615516A 1983-04-25 1984-04-17 Aryl and aralkyl sulfonyl l-prolines Expired - Lifetime CA1271966A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000615516A CA1271966A (en) 1983-04-25 1984-04-17 Aryl and aralkyl sulfonyl l-prolines

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48847783A 1983-04-25 1983-04-25
CA000452213A CA1266661A (en) 1983-04-25 1984-04-17 Acylmercaptoalkanoyl and mercaptoalkanoyl derivatives of aryl and aralkyl sulfinyl or sulfonyl l-prolines
CA000615516A CA1271966A (en) 1983-04-25 1984-04-17 Aryl and aralkyl sulfonyl l-prolines
US488,477 1995-06-08

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000452213A Division CA1266661A (en) 1983-04-25 1984-04-17 Acylmercaptoalkanoyl and mercaptoalkanoyl derivatives of aryl and aralkyl sulfinyl or sulfonyl l-prolines

Publications (2)

Publication Number Publication Date
CA1271966C true CA1271966C (en) 1990-07-24
CA1271966A CA1271966A (en) 1990-07-24

Family

ID=34117156

Family Applications (2)

Application Number Title Priority Date Filing Date
CA000452213A Expired - Lifetime CA1266661A (en) 1983-04-25 1984-04-17 Acylmercaptoalkanoyl and mercaptoalkanoyl derivatives of aryl and aralkyl sulfinyl or sulfonyl l-prolines
CA000615516A Expired - Lifetime CA1271966A (en) 1983-04-25 1984-04-17 Aryl and aralkyl sulfonyl l-prolines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA000452213A Expired - Lifetime CA1266661A (en) 1983-04-25 1984-04-17 Acylmercaptoalkanoyl and mercaptoalkanoyl derivatives of aryl and aralkyl sulfinyl or sulfonyl l-prolines

Country Status (1)

Country Link
CA (2) CA1266661A (en)

Also Published As

Publication number Publication date
CA1266661C (en) 1990-03-13
CA1271966A (en) 1990-07-24
CA1266661A (en) 1990-03-13

Similar Documents

Publication Publication Date Title
ES8700672A1 (en) Phenobarbital and carbamazepine enzyme inhibitors.
AU589686B2 (en) Intermediates for the production of amino and substituted amino phosphinylalkanoyl compositions
ES2070660A1 (en) Intermediates for preparing retroviral protease inhibiting compounds
CA1273019C (en) Enkephalinase inhibitors
ES8306710A1 (en) Bicyclic compounds, their production and use.
IL104716A0 (en) Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ace
ATE24516T1 (en) AMINO AND SUBSTITUTED AMINOPHOSPHINYLAKANOYL COMPOUNDS.
ES8504211A1 (en) Derivatives of oligoglucosides
EP0199152A3 (en) Lipoxygenase inhibiting compounds
TW372972B (en) Antiretroviral acyl compounds
EP0202654A3 (en) 5-carboxy-1,4-dihydropyrimidine derivatives
GB8502258D0 (en) Organic compounds
YU127887A (en) Process for obtaining new derivatives of substituted 2-aminooxi-2-propenoic acid
ES2010145A6 (en) 2-picolylamine derivates.
ES8801545A1 (en) Heterocyclic amino compounds.
CA1271966C (en) Aryl and aralkyl sulfonyl l-prolines
CA1264753C (en) 2-pyridylcarboxamides
IE781193L (en) Nitroso-ureas
GB1513883A (en) 3-(4-amino-and 4-acylamino-piperazin-1-ylalkyl)indoles
MX9603348A (en) Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase.
CA1267150C (en) Thiabicycloheptane substituted amino prostaglandin analogs
ES8306997A1 (en) 5 Fluoro PGI compounds.
ES479444A1 (en) Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
ATE26268T1 (en) 2-ALKOXYAMINOSULFONYLBENZENESULFONYL UREA DERIVATIVES.
ATE21511T1 (en) CYCLIC AMIDES.

Legal Events

Date Code Title Description
MKLA Lapsed
MKLA Lapsed

Effective date: 20020724